Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Myriad Genetics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 213 | 3 | 197 | −13 |
| Shares | 79.3M | 7.06K | 78.3M | −982.0K (−1.2%) |
| Value | $2.56B | $227.0K | $2.16B | −$400.7M (−15.7%) |
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Myriad Genetics Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connectus Wealth, LLC | 84,754 | $2.34M | 0.09% |
| First Trust Advisors LP | 83,049 | $2.29M | 0.00% |
| Yousif Capital Management, LLC | 70,818 | $1.96M | 0.02% |
| Duality Advisers, LP | 42,740 | $1.18M | 0.13% |
| Allspring Global Investments Holdings, LLC | 39,013 | $1.08M | 0.00% |
| Assenagon Asset Management S.A. | 31,243 | $862.0K | 0.00% |
| Jane Street Group, LLC | 21,102 | $583.0K | 0.00% |
| Tudor Investment Corp Et Al | 13,872 | $383.0K | 0.01% |
| Parallax Volatility Advisers, L.P. | 8,008 | $221.0K | 0.00% |
| Vident Investment Advisory, LLC | 7,374 | $204.0K | 0.01% |
| CWM, LLC | 3,576 | $99.0K | 0.00% |
| Itau Unibanco Holding S.A. | 2,927 | $81.0K | 0.00% |
| Spire Wealth Management | 1,740 | $48.0K | 0.00% |
| Dark Forest Capital Management LP | 401 | $11.0K | 0.00% |
| Surevest, LLC | 206 | $6.00K | 0.00% |
| Sageworth Trust Co of South Dakota | 227 | $6.00K | 0.01% |
| Cambridge Trust Co | 155 | $4.00K | 0.00% |
| Signaturefd, LLC | 93 | $3.00K | 0.00% |
| Glassman Wealth Services | 84 | $2.00K | 0.00% |
| Concord Wealth Partners | 24 | $1.00K | 0.00% |
| JFS Wealth Advisors, LLC | 6 | $0 | 0.00% |
| Schubert & Co | 5 | $0 | 0.00% |
| Covestor Ltd | 17 | $0 | 0.00% |
| Sofos Investments, Inc. | 616 | – | – |
Sold out (37)
Institutions that held Myriad Genetics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (3)
Institutions that held Myriad Genetics Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Eudaimonia Partners, LLC | 6,732 | $217.0K |
| Sonora Investment Management, LLC | 260 | $8.00K |
| BBVA USA | 71 | $2.00K |